Dr. Vincent Vieillard

Centre National de la Recherche Scientifique, France

Email: vincent.vieillard@upmc.fr

Qualifications

1995  Ph.D., University Paris 11, France

1992  M.Sc., Pasteur Institute, France

Publications (Selected)

1. Vieillard V, Lauret E, Rousseau V & De Maeyer E. (1994). Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc. Natl. Acad. Sci. USA 91: 2689-2693.
2. Vieillard V, Cremer, I, Lauret E, Rozenbaum W, Debré P, Autran B & De Maeyer E. (1997). Interferon beta transduction of PBL from HIV-infected donors increases Th1-type cytokine production, and improves the proliferation response to recall antigens. Proc. Natl. Acad. Sci. USA 94: 11595-11600.
3. Hadida F, Vieillard V, Autran B, Clark-Lewis I, Baggiolini M & Debré P. (1998). HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J. Exp. Med. 188: 609-614.
4. Vieillard V, Strominger JL & Debré P. (2005). The critical role of an NKp44 ligand in the CD4+ T depletion by activated NK cells during HIV infection. Proc. Natl. Acad. Sci. USA. 102: 10981-10986.
5. Vieillard V, Le Grand R, Dausset J & Debré P. (2008). A new vaccine strategy against AIDS: HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques. Proc. Natl. Acad. Sci. USA. 105: 2100-2104.
6. Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G & Debré P. (2010). HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathogens 6, e1000975.